InsiderLens

31 Mar 2026CONVERSIONCogent Biosciences, Inc.7,000,000—

indirect· Fairmount Healthcare Fund II LP

31 Mar 2026SALECogent Biosciences, Inc.7,000,00034.66 USD

indirect· Fairmount Healthcare Fund II LP

31 Mar 2026CONVERSIONCogent Biosciences, Inc.28,0000.00 USD

indirect· Fairmount Healthcare Fund II LPderiv

22 Jan 2026SALECogent Biosciences, Inc.3,500,00036.40 USD

indirect· Fairmount Healthcare Fund II LP

10 Jul 2025PURCHASECogent Biosciences, Inc.2,777,7779.00 USD

indirect· Fairmount Healthcare Fund II LP

17 Jun 2025GRANT_AWARDApogee Therapeutics, Inc.14,4610.00 USD

indirect· By: Tomas Kiselakderiv

17 Jun 2025GRANT_AWARDApogee Therapeutics, Inc.14,4610.00 USD

indirect· By: Peter Harwinderiv

09 Jun 2025EXERCISEViridian Therapeutics, Inc.\DE1,6007.80 USD

indirect· Fairmount Healthcare Fund II LP

10 Jun 2025EXERCISEViridian Therapeutics, Inc.\DE12,50012.31 USD

indirect· Fairmount Healthcare Fund II LP

09 Jun 2025EXERCISEViridian Therapeutics, Inc.\DE1,6000.00 USD

indirect· By: Peter Harwinderiv

10 Jun 2025EXERCISEViridian Therapeutics, Inc.\DE12,5000.00 USD

indirect· By: Peter Harwinderiv

16 Sept 2024CONVERSIONZenas BioPharma, Inc.709,794—

indirect· By Fairmount Healthcare Fund II LP

16 Sept 2024CONVERSIONZenas BioPharma, Inc.301,077—

indirect· By Fairmount Healthcare Fund II LP

16 Sept 2024CONVERSIONZenas BioPharma, Inc.252,890—

indirect· By Fairmount Healthcare Fund II LP

16 Sept 2024CONVERSIONZenas BioPharma, Inc.41,130—

indirect· By Fairmount Healthcare Fund II LP

16 Sept 2024PURCHASEZenas BioPharma, Inc.300,00017.00 USD

indirect· By Fairmount Healthcare Fund II LPfirst after silence

16 Sept 2024CONVERSIONZenas BioPharma, Inc.2,614,287—

indirect· By Fairmount Healthcare Fund II LPderiv

12 Sept 2024GRANT_AWARDZenas BioPharma, Inc.37,0000.00 USD

indirect· By Tomas Kiselakderiv

16 Sept 2024CONVERSIONZenas BioPharma, Inc.6,163,236—

indirect· By Fairmount Healthcare Fund II LPderiv

16 Sept 2024CONVERSIONZenas BioPharma, Inc.2,195,871—

indirect· By Fairmount Healthcare Fund II LPderiv

16 Sept 2024CONVERSIONZenas BioPharma, Inc.357,143—

indirect· By Fairmount Healthcare Fund II LPderiv

10 Jun 2024EXERCISECogent Biosciences, Inc.1,500,000—

indirect· Fairmount Healthcare Fund II LP

10 Jun 2024EXERCISECogent Biosciences, Inc.1,5000.00 USD

indirect· Fairmount Healthcare Fund II LPderiv

23 May 2024GRANT_AWARDDianthus Therapeutics, Inc. /DE/11,0000.00 USD

indirect· See footnotederiv

28 Mar 2024OTHERCogent Biosciences, Inc.286,851—

indirect· Fairmount Healthcare Fund II LP

Fairmount Funds Management LLC.

Fairmount Funds Management LLC.